Ideaya Biosciences Inc (IDYA)
Healthcare
Biotechnology
35.50 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Ideaya Biosciences Inc (IDYA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -71 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -12 | -28 | -39 | 55 | -56 | -87 | -115 | -248 | -71 | |
| 0.4 | 0.9 | 1.2 | 1.4 | 1.7 | 2.1 | 4.0 | 3.8 | 4.6 | |
| 0.1 | 1.0 | 2.2 | 3.6 | 8.2 | 12 | 18 | 35 | 46 | |
| -2.3 | 4.2 | 1.7 | 4.2 | 8.2 | 12 | – | – | – | |
| 1.6 | 1.7 | -0.3 | 84 | -18 | -42 | -13 | 12 | 1.9 | |
| 1.8 | 1.7 | 1.4 | 0.5 | 2.6 | 3.4 | 2.4 | 3.9 | 2.4 | |
| -8.9 | -63 | 2.3 | -146 | -70 | -33 | -158 | -503 | 70 | |
| 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 17 | 105 | 51 | 1.2 | 88 | 88 | – | – | – | |
| 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 17 | 105 | 51 | 129 | 145 | 97 | 363 | 678 | 30 | |
| -3.7 | 15 | 14 | 38 | 20 | -23 | 89 | -73 | 28 | |
| -14 | -29 | -41 | 55 | -58 | -91 | -118 | -251 | -73 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.